title: Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100].
authors.affiliation: Mazankowski Alberta Heart Institute and University of Alberta, Edmonton, Alberta, Canada. Electronic address: Robert.Welsh@albertahealthservices.ca.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Welsh
authors.affiliation: Division of Cardiology, Duke Clinical Research Institute, Duke Medicine, Durham, NC.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Roe
authors.affiliation: Université Paris-Diderot, Sorbonne Paris Cité, FACT, DHU-FIRE, AP-HP and INSERM - U-1148, Paris, France; NHLI, Royal Brompton Hospital, Imperial College, London, United Kingdom.
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
authors.affiliation: Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
authors.forename: Stefan
authors.initials: S
authors.lastname: James
authors.affiliation: Division of Cardiology, Duke Clinical Research Institute, Duke Medicine, Durham, NC.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Povsic
authors.affiliation: University of Freiburg, Freiburg, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Bode
authors.affiliation: Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
authors.forename: Charles Michael
authors.initials: CM
authors.lastname: Gibson
authors.affiliation: Division of Cardiology, Duke Clinical Research Institute, Duke Medicine, Durham, NC.
authors.forename: Erik Magnus
authors.initials: EM
authors.lastname: Ohman